title: In-laboratory removal of femoral sheath following protamine administration in patients having intracoronary stent implantation.
abstract: Two hundred twenty-eight patients with successful coronary stent implantation were randomized either to protamine administration and femoral sheath removal (group I, n = 117) or no heparin neutralization and delayed sheath removal (group II, n = 111). The hospital stay after treatment was shorter in patients receiving protamine; therefore, protamine use for neutralizing circulating heparin may be safely administered immediately after stent implantation.
authors.affiliation: Hospital Reina Sofía, University of Córdoba, Spain.
authors.forename: M
authors.initials: M
authors.lastname: Pan
authors.forename: J
authors.initials: J
authors.lastname: Suárez de Lezo
authors.forename: A
authors.initials: A
authors.lastname: Medina
authors.forename: M
authors.initials: M
authors.lastname: Romero
authors.forename: E
authors.initials: E
authors.lastname: Hernández
authors.forename: J
authors.initials: J
authors.lastname: Segura
authors.forename: F
authors.initials: F
authors.lastname: Melian
authors.forename: F
authors.initials: F
authors.lastname: Wangüemert
authors.forename: M
authors.initials: M
authors.lastname: Landin
authors.forename: F
authors.initials: F
authors.lastname: Benítez
authors.forename: M
authors.initials: M
authors.lastname: Amat
authors.forename: F
authors.initials: F
authors.lastname: Velasco
authors.forename: A
authors.initials: A
authors.lastname: Torres
mesh_terms: D000925:Anticoagulants / Q000627:therapeutic use; D003327:Coronary Disease / Q000628:therapy*; D017985:Dalteparin / Q000627:therapeutic use; D005260:Female; D005263:Femoral Artery; D006470:Hemorrhage / Q000517:prevention & control; D006493:Heparin / Q000627:therapeutic use; D006494:Heparin Antagonists / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011292:Premedication; D011479:Protamines / Q000627:therapeutic use*; D015607:Stents; D013927:Thrombosis / Q000517:prevention & control
chemical_list: D000925:Anticoagulants; D006494:Heparin Antagonists; D011479:Protamines; D006493:Heparin; D017985:Dalteparin